awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38866636-0C646D11-FBBB-4F58-BDF9-471C43137682
Q38866636-0C646D11-FBBB-4F58-BDF9-471C43137682
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38866636-0C646D11-FBBB-4F58-BDF9-471C43137682
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
P2860
Q38866636-0C646D11-FBBB-4F58-BDF9-471C43137682
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38866636-0C646D11-FBBB-4F58-BDF9-471C43137682
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9617e939177741147e02b09a99935204ebd33b77
P2860
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.